MedTrace Logo

Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors

NCT06305494 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2024-04-25

No results posted yet for this study

Summary

Women often face common cancers like ovarian, uterine, and cervical cancers. Improvements in cancer detection and treatment mean more women survive. However, survivors can encounter challenges like ongoing pain, treatment complications, and fertility issues.

Treating these cancers often involves surgeries that might include removing ovaries or using pelvic radiation. This can trigger menopause in younger women, causing problems like vaginal dryness, itching, and urinary issues.

Women who've gone through menopause often deal with these symptoms, affecting their daily lives, confidence, and intimate relationships. Though treatments are available, lack of awareness, embarrassment, and not discussing these issues with doctors can make managing them difficult.

The main treatment for these symptoms is using vaginal estrogen, but it might not be suitable for some cancer survivors. Non-hormonal options like lubricants and moisturizers are alternatives. This study in Thailand aiming to explore how common these issues are among gynecological cancer survivors, their feelings about it, and how it affects their quality of life.

Conditions

  • Atrophic Vaginitis
  • Gynecologic Cancer
  • Lower Urinary Tract Symptoms

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Apiwat Jongjakapun, MD · Khon Kaen University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-14
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06305494 on ClinicalTrials.gov